SEC Filing Details

Document Details

Form

Filing Date

10/07/2021

Document Date

09/27/2021

Form Description

Initial filing by director officer or owner of more than ten percent.

Filing Group

3,4,5

Company

Eagle Pharmaceuticals, Inc.

Issuer

EAGLE PHARMACEUTICALS, INC.

View HTML

Change % Volume Data as of 03/31/2023 11:39 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.